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Abstract Despite the economic impact of the infectious
myonecrosis virus (IMNV) on shrimp farms in several
countries, no method for immunological detection is cur-
rently available. With the aim of developing immuno-
diagnostic methods for IMNV detection in infected shrimps,
a recombinant fragment of the IMNV major capsid protein
gene encoding amino acids 105–297 (rIMNV105–297) was
heterologously expressed in Escherichia coli and used to
immunize Balb/c mice, generating monoclonal antibodies
(MAbs). Six hybridomas were obtained, and four of these
recognized the presence of IMNV in tissue homogenates
from naturally infected shrimps by immunodot blot assay.
Among these MAbs, three were able to detect a *100-kDa
protein, which corresponds to the predicted mass of the
IMNV major capsid protein, as well as viral inclusion
bodies in muscle fibroses by western blot and immuno-
histochemistry. Two MAbs showed high specificity and
sensitivity, showing no cross-reaction with healthy shrimp
tissues in any assays, indicating their usefulness for IMNV
detection.
Introduction
The shrimp farming industry is an important agribusiness
worldwide, accounting for annual incomes of over US$
10 billion due to export of penaeid shrimps, which is one of
the most important internationally traded fisheries com-
modities [1]. However, since 1980 the penaeid shrimp
farming industry has been affected by at least four pandemic
viruses, incurring major economic losses [2]. Among these,
infectious myonecrosis virus (IMNV), also known as pen-
aeid shrimp myonecrosis virus (PsIMNV), was identified
most recently and has been shown to have a major economic
impact [3]. IMNV is a non-enveloped virus containing
a 7560-nucleotide non-segmented double-stranded RNA
genome with two open reading frames (ORFs). The viral
particles are icosahedral in shape, with a diameter of 40 nm
and fiber-like protrusions on the surface [4–6]. ORF1
encodes a putative RNA-binding protein and the 901-aa
major capsid protein, while ORF2 encodes a 736-aa protein
that presents typical motifs of an RNA-dependent RNA
polymerase (RdRp) [4, 5]. Phylogenetic analysis based
on the RdRp identified IMNV as a member of the family
Totiviridae [4]. Most of the viruses from this family cause
latent and avirulent infections, with IMNV being the only
member to infect a host that is not a fungus or a protozoan
and that has been implicated in causing disease [6]. Typical
IMNV infection results in clinical signs consisting of
extensive necrotic areas in striated muscles with opaque
appearance, particularly in the distal abdominal segments
and the tail fan [3, 4, 7]. In cultured penaeid shrimp, infec-
tion results in a chronic, persistent, and slowly progressive
disease that results in cumulative mortality rates of up to
70% [3]. Once confined to a geographic region, global
shrimp commerce has favored the spread of IMNV world-
wide, which was not followed by the characterization of the
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etiological agents [8]. The first report of an IMNV epizootic
event was in Brazil in 2002 in a shrimp farm located in the
coastal area of the state of Piauı´, in the northeastern region
[3, 7]. Since then, the virus silently and progressively spread
to farms in other Brazilian states [9–11] as well as to other
countries such as Indonesia [12], causing a social and eco-
nomic impact.
Since an efficient method to control the spread of IMNV
has not yet been reported, the search for sensitive and spe-
cific diagnostic methods that can be employed under field
conditions and are suitable to simultaneously analyze a large
number of samples is highly desirable. Nowadays, the
diagnosis of IMNV infection relies basically on clinical
signs [7], histopathological examination [13] and molecular
techniques. Compared to the last of these, the first two
methods have the disadvantage poor specificity and thus are
prone to give false negative results. On the other hand,
molecular techniques are usually very sensitive and specific
but require trained personnel and specialized equipment,
making them expensive and difficult to implement on
shrimp farms. Despite these drawbacks, several molecular
methodologies have been described recently for IMNV
detection, such as RT-PCR [14], nested-PCR [12], real-time
qPCR [9] and new alternatives like RT LAMP LFD, which
combines nucleic acid amplification under isothermal con-
ditions and chromatographic visualization [15].
In contrast to nucleic acid-based approaches, it is note-
worthy to mention that no efforts have been made towards
the development of immunological methods to detect
IMNV, probably due to limited knowledge of the IMNV
protein expression profile and the lack of specific tools like
monoclonal antibodies directed against the virus. Diagnostic
methods employing MAbs have been used in the diagnosis
of other viral infections in farm-reared shrimps [16–23].
Some of these MAbs-based methods, such as ELISA and
western blot, are routinely performed in laboratories, but
simple, low-cost methods allowing accurate diagnosis by
untrained personnel under field conditions, such as latex
agglutination and immunochromatographic strip tests, are
urgently needed. In this study, we report the generation and
characterization of MAbs directed against a recombinant
portion of the IMNV major capsid protein (rIMNV105–297)
that specifically recognize the native protein in naturally
infected shrimps, allowing the development of immuno-
logical diagnostic methods for IMNV infection.
Materials and methods
Shrimp and sample preparation
Pacific white shrimps, Litopenaeus vannamei, that were
naturally infected with IMNV were obtained from shrimp
farms at Piauı´ State, Northeastern Brazil. Animals exhib-
iting clinical signs had IMNV infection confirmed by
RT-PCR using specific primers to the IMNV major capsid
protein gene as described below. Samples from abdominal
muscle of infected shrimps were dissected, preserved in
RNAlater
TM
(Qiagen, Germantown, USA) or Davidson’s
alcohol–formalin–acetic solution for molecular and
immunological assays, respectively, or frozen at -80C.
Tissue samples taken from healthy animals were also
analyzed by RT-PCR and used as negative controls in all
experiments.
RNA isolation and PCR amplification
Total RNA was extracted from all samples using the
TRIzol reagent (Invitrogen, Carlsbad, USA) according to
the manufacturer’s instructions. RNA concentration and
quality were assessed spectrophotometrically at 260 and
280 nm using NanoVue
TM
equipment (GE-Healthcare,
Buckinghamshire, UK). After cDNA synthesis using
M-MLV reverse transcriptase, an oligo dT(12) primer (Invit-
rogen) and 1 lg of total RNA as template, specific primers
IMNV105–297-F (5
0-CAT ATG GGG CAA TTA CGG TTA
CAG GG-30), and IMNV105–297-R (50-CGG GAT CCG
TAT ACA TAC CAA ATG GCC-30) were used for PCR
amplification of the region encoding amino acids 105–297
of the hydrophilic region of IMNV major capsid protein
(GenBank accession no. AY570982.1) as determined by
the Kyte and Doolittle method using the ProtScale software
(http://www.expasy.ch/tools/protscale.html). To simplify
the cloning procedures, NdeI and BamHI restriction sites
were added to the 50 end of the IMNV105–297-F and
IMNV105–297-R primers (underlined nucleotides), respec-
tively. Amplification of the IMNV105–297 region by PCR
was performed in a Mastercycler Gradient thermocycler
(Eppendorf, Hamburg, DE) using 1U of Taq DNA poly-
merase (LGC Biotechnology, Cotia, Brazil) in buffer
containing 0.2 mM of each dNTP, 1.5 mM MgCl2, and
0.4 lM of each primer. The following thermal profile was
used: 94C for 5 min, followed by 30 cycles of 94C for
45 s, 60C for 45 s, and 72C for 45 s, with a final
extension step of 72C for 10 min. The amplification
products were resolved in 1% agarose gels, stained with
ethidium bromide, visualized in a Macrovue-UV20 trans-
illuminator (Hoefer, San Francisco, CA, USA), and
recorded digitally.
IMNV105–297 cloning
The amplification product of 600 bp that was obtained was
cloned into pGEM-T Easy Vector (Promega, Madison,
USA) and used to transform Escherichia coli DH5a (Pro-
mega), which was then cultured on LB-agar plates
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containing IPTG (1 mM), X-GAL (20 lg/ml) and ampi-
cillin (100 lg/ml). Plasmid DNA was extracted from
positive clones by standard methods and were checked by
sequencing the inserts in both directions in a MegaBACE
1000 DNA Analysis System (GE-Healthcare) using
DYEnamic ET dye terminators as instructed by the
manufacturer. The quality of all sequences thus obtained
was assessed using the Phred/Phrap/Consed software
(http://www.phrap.org), which allowed the determination
of a high-quality consensus sequence [24]. An identity
check was performed by similarity analysis using the
BlastP algorithm (http://blast.ncbi.nlm.nih.gov/) based on
the IMNV105–297 deduced amino acid sequence obtained
using the Expasy proteomic server (http://ca.expasy.org/).
The deduced amino acid sequence was aligned with major
capsid protein sequences from Brazilian and Indonesian
IMNV isolates (GenBank accession no. AY570982 and
EF061744, respectively) using the ClustalX program [25]
in an attempt to identify variability within the fragment
chosen for expression. Once its identity was confirmed, the
IMNV105–297 sequence was subcloned into the expression
vector pET-14b (Novagen, Gibbstown, USA) by BamHI/
NdeI digestion followed by ligation with T4 DNA ligase.
After transformation of E. coli BL21/DE3 competent cells
(Novagen) and growth in LB-agar broth containing 100 lg/ml
ampicillin, all positive clones were further checked by
sequencing as described above to assure identity and the
maintenance of the open reading frame.
Heterologous expression and purification
of rIMNV105–297
The clones containing the IMNV105–297 fragment were
grown in LB broth containing 100 lg/ml of ampicillin and
1 mM isopropyl-D-thiogalacto-pyranoside (IPTG) (Sigma-
Aldrich, St. Louis, USA) at different temperatures (37, 27,
18C) and with different induction periods (1.5, 3 and
15 h) to achieve the best recombinant expression levels.
The bacterial cultures were then centrifuged (5,0009g for
10 min at 4C), and the pellet was suspended in 20 mM
Tris–HCl (pH 7.0) and sonicated three times for 30 s
at 12 W, followed by another centrifugation step
(10,0009g for 20 min) to obtain the soluble and insoluble
fractions. Protein profiles of both fractions were resolved
by 15% SDS-PAGE at 25 mA for 2 h and, after staining
the gel with 0.1% Coomassie Brilliant Blue R-250 for 2 h,
the results were recorded digitally. Since the majority of
rIMNV105–297 was detected in the insoluble fraction, bac-
terial pellets were treated with a denaturing lysis buffer
(8 M CO(NH2)2, 100 mM NaH2PO4, 100 mM Tris–HCl,
pH 8.0) at 60C for 1 h, with agitation. After centrifugation
(12,0009g for 30 min at 4C), the supernatant fraction
containing the N-terminal 6-histidine-tagged rIMNV105–297
was purified using Ni-NTA Agarose (Qiagen) according to
manufacturer’s protocol. After four cycles of dialysis for
12 h each in dialysis buffer (100 mM Tris–HCl, 500 mM
NaCl, 0.5 mM EDTA, 10% glycerol, pH 8.5), the protein
was quantified [26]. The purified protein was resolved
by15% SDS-PAGE as described above and electroblotted
onto a nitrocellulose membrane (GE-Healthcare) soaked
with blotting buffer (25 mM Tris, 192 mM glycine, 20%
methanol, pH 8.3). Western blot assays were carried out
to assess the expression of rIMNV105–297. For this, mem-
branes were blocked with 5% non-fat milk for 90 min,
incubated for 1 h with anti-HisTag MAb (Sigma-Aldrich)
at 25C in blotting buffer, washed 5 times in TBS buffer
with 0.1% Tween and then incubated with HRP-conjugated
goat anti-mouse total immunoglobulin (Sigma-Aldrich) for
1 h at 25C. Detection was carried out using ECL reagent
(GE-Healthcare) and exposure to radiographic films
(GE-Healthcare), which were developed using an automated
SRX-101A film processor (Konica-Minolta, Tokyo, Japan).
Immunization and MAb production
MAbs were prepared based on procedures described by
Ko¨hler and Milstein [27] and Yokoyama et al. [28] with
minor modifications. All procedures involving experimental
animals were approved in advance by the UFSC Ethics
Committee for Animal Care. 5–6- to 8-week-old Balb/c
mice from breeding stocks maintained at the animal facility
of the Departamento de Microbiologia, Imunologia e Para-
sitologia, UFSC, were immunized subcutaneously with
50 lg of purified rIMNV105–297 mixed with complete Fre-
und’s adjuvant (Sigma-Aldrich) at a 1:1 ratio. Ten days later,
a second subcutaneous immunization was performed using
the same amount of antigen mixed with incomplete Freund’s
adjuvant (Sigma-Aldrich). Two additional doses of 50 lg
rIMNV105–297 were administered without any adjuvant by
the intraperitoneal route at 10-day intervals. Four days after
the last immunization, mouse sera were obtained from blood
collected from the retro-orbital plexus to assess antibody
production by ELISA as described below. Spleens from the
mice with the highest antibody titers against rIMNV105–297
were removed under aseptic conditions, and splenocytes
were fused with P3X63Ag8.653 myeloma cells (ATCC
number CRL-1580) at a ratio of 5:1 using 50% polyethyl-
eneglycol-4000 (Sigma-Aldrich) as fusion reagent. The
resulting hybridomas were grown in RPMI-1640 medium
(Cultilab, Campinas, Brazil) containing 20% fetal calf
serum (Cultilab), and a 1% antibiotic and antimycotic
cocktail (Sigma-Aldrich), supplemented with 0.1 mM
hypoxanthine, 0.4 lM aminopterin, and 16 lM thymidine
(Sigma-Aldrich). Two weeks after fusion, hybridomas were
screened by indirect ELISA for antibody secretion and
recognition of purified rIMNV105–297 as described below.
Monoclonal antibodies against IMNV major capsid protein 11
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Hybridomas with the highest titers against the recombinant
protein in their supernatants were further subjected to two
rounds of cloning by the limiting dilution method and stored
in liquid nitrogen. The immunoglobulin isotype of the MAbs
was determined by sandwich ELISA using an SBA Clono-
typing System/HRP (Southern Biotech, Birmingham, USA),
following the manufacturer’s instructions.
Indirect ELISA
Ninety-six-well microplates (Costar, Lowell, USA) were
coated for 3 h with 50 ng/well of rIMNV105–297. After
blocking at 4C for 12 h with 3% bovine serum albumin in
PBS-T (PBS supplemented with Tween-20 0.05%), incu-
bation of each hybridoma supernatant was carried out for 1 h
at 37C. As positive and negative controls, sera from mice
immunized with rIMNV105–297 and RPMI-1640 medium,
respectively, were used. After three wash cycles with
PBS-T, incubation with HRP-conjugated goat anti-mouse
immunoglobulin (Sigma-Aldrich) was performed for 1 h at
37C, followed by five washes with PBS-T and addition of
the substrate o-phenylendiamine (0.4%; Sigma-Aldrich) and
0.03% H2O2 in 0.1 M phosphate-citrate buffer (pH 5.6).
Absorbance was measured by spectrophotometry at 495 nm
in a Sunrise
TM
Basic device (Tecan, Ma¨nnedorf, Sweden).
Detection of IMNV in tissues from naturally
infected shrimps
Frozen striate muscle from IMNV-infected and uninfected
shrimps were macerated using sterile pestles for 5 min in
lysis buffer (0.2 mM Tris–HCl, 400 mM NaCl, pH 7.4)
containing a protease inhibitor cocktail (Sigma-Aldrich).
The homogenate was subjected to three cycles of sonica-
tion for 30 s at 12 W and were stored at -20C for im-
munodot blot and western blot assays. For immunodot blot,
100 ng of purified rIMNV105–297, 1 lg of IMNV-infected,
and 1 lg of uninfected striated muscle homogenates were
spotted onto nitrocellulose membranes. These same sam-
ples were also used for western blot assays along
with homogenates of E. coli BL21/DE3 expressing
rIMNV105–297 or not, which were resolved and transferred
as described above. After incubation of the membranes at
25C for 1 h with each MAb generated in this study as well
as with anti-rabies virus MAb, which was used as a control,
both assays were carried out and developed as described
above.
Immunohistochemical analysis
MAbs that recognized the IMNV major capsid protein in
western blot assays were further tested using immunohis-
tochemical assays. For this, healthy and IMNV-infected
L. vannamei tissues were fixed for 48 h with Davidson’s
solution, followed by washes with 70% ethanol. Sections
measuring 3 lm were taken from paraffin-embedded tis-
sues, and antigen retrieval was performed by immersion of
the slides in 10 mM trisodium citrate-buffer (pH 6.0) at
95–98C for 45 min. After blocking nonspecific binding
with normal goat serum, tissue sections were incubated
with anti-IMNV105–297 MAbs for 15 h at 4C using an anti-
rabies virus MAb as a negative control. Following washes
of the tissue sections with PBS, development was per-
formed using an Envision
TM
plus horseradish peroxidase kit
(Dako Cytomation, Glostrup, Denmark). Slides were then
counterstained with Harris’s hematoxylin solution, and
images were acquired and digitally recorded using an
Eclipse 50i microscope (Nikon, Tokyo, Japan) coupled to a
DS-5M-L1 camera (Nikon).
Results and discussion
Amplification, cloning, and sequence alignment
of IMNV105–297
The nucleotide sequence encoding a hydrophilic region of
the IMNV major capsid protein, between residues Ala-105
and Tyr-297 (IMNV105–297), was successfully amplified by
PCR using the specific primers described herein. The
cDNA template was obtained from IMNV-infected animals
collected between 2008 and 2009 in the same geographic
region where the first IMNV outbreak occurred in Brazil in
2002. The expected PCR product of 600 bp was ultimately
cloned into an expression vector in the correct frame, as
assessed by sequencing both strands from four distinct
clones. The sequences obtained were of high quality (phred
C20), and all were used to obtain a consensus sequence
that revealed a high degree of nucleotide identity with
IMNV genome sequences available in the GenBank data-
base, confirming the identity of the clone fragment. Clu-
stalX alignment showed that the IMNV105–297 deduced
amino acid sequence was 99% identical to a previously
reported IMNV sequence from Brazil [4], with a single
amino acid change at position 294 (F–C). Moreover, 98%
identity was found when IMNV105–297 was compared to
sequences of IMNV isolated in Indonesia [12], with amino
acid changes at positions 223 (A–V) and 294 (F–C). The
sequence data were submitted to GenBank with the
accession number HM357803. Considering the limited
nucleotide variability in the capsid region between amino
acids 105 and 297, resulting in only two amino acid dif-
ferences due to non-synonymous substitutions, it is possi-
ble to infer that epitopes localized in this portion are likely
to be highly similar among different IMNV isolates,
regardless of the geographic region considered.
12 M. Borsa et al.
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Expression and characterization of rIMNV105–297
Being one of the less hydrophobic regions of the major
capsid protein, the IMNV105–297 portion was then selected
for recombinant expression (rIMNV105–297) (Fig. 1)
because epitopes might potentially be exposed on the
virion surface, allowing their recognition by MAbs. The
optimal expression of rIMNV105–297 was achieved after
15 h of induction with 1 mM IPTG at 27C (Fig. 2a),
although expression was detected by SDS-PAGE under all
conditions tested (data not shown). Comparative analysis
of soluble and insoluble fractions of bacterial cultures
expressing rIMNV105–297 by SDS-PAGE showed a prom-
inent and exclusive expression of a *25-kDa protein in the
insoluble fraction, which was absent in bacteria trans-
formed with mock vector control (Fig. 2a). Western blot
analysis showed that anti-HisTag antibody specifically
recognized a single band of *25 kDa that was present
exclusively in lysates of rIMNV105–297-expressing bacteria
and did not recognize any proteins in E. coli mock control
lysates (Fig. 2a).
Production and characterization of anti-rIMNV105–297
MAbs
Eighteen of the 219 hybridomas that were generated (8.2%)
were positive for anti-rIMNV105–297 antibody secretion, as
revealed by indirect ELISA on an initial screening. After
2 weeks under selective culture, six hybridomas that
remained stable in terms of growth and antibody secretion
were selected and cloned, allowing the establishment of
monoclonal cell lines named 1.3H, 1.1D, 3.3G, 3.9G, 4.6C,
and 5.4H. Isotyping carried out by sandwich ELISA
identified MAbs 1.3H and 4.6C as belonging to the IgG1
subclass and MAbs 1.1D, 3.3G, 3.9G, and 5.4H as IgM.
MAbs 1.3H, 1.1D, 3.3G, 4.6C, and 5.4H were able
to recognize the expected *25-kDa protein in pET-
IMNV105–297-transformed E. coli lysates in western blot
assays (Fig. 2b). These MAbs have also recognized a
protein of *50 kDa, which could be a dimeric form of
rIMNV105–297 due to disulphide bonds between cysteine
residues of two monomeric units of the recombinant pro-
tein (Fig. 2b). Interestingly, western blot using anti-HisTag
MAb did not recognize the *50-kDa band (Fig. 2a), which
can be explained by conformational changes in the dimeric
form that might be blocking the HisTag tail. The 3.9G
MAb did not recognize the purified rIMNV105–297 or any
protein from control bacterial extracts. The MAbs descri-
bed in the present study did not recognize any proteins in
normal E. coli lysates nor in lysates from bacteria trans-
formed with mock plasmids, confirming the specificity of
these antibodies to the IMNV105–297. The anti-rabies-virus
Fig. 1 Schematic representation of rIMNV105–297. The N-terminal
6-histidine-tagged rIMNV105–297 encompasses the amino acids
105–297 of the 901-aa major capsid protein encoded by nucleotides
2248–4953 of IMNV ORF1
Fig. 2 Heterologous expression and purification of a recombinant
fragment of the IMNV major capsid protein (rIMNV105–297) and
reactivity of anti- rIMNV105–297 MAbs against E. coli homogenates
by western blot. a 15% SDS-PAGE gel stained with Coomassie blue
showing the protein profile of E. coli BL21/DE3 expressing
rIMNV105–297 and western blot using anti-HisTag antibody.
b Western blot of the same samples resolved by SDS-PAGE using
the MAbs produced in this work, showing their ability to bind to
rIMNV105–297. M, BenchMark
TM
protein ladder (Invitrogen); 1, E. coli
mock control, transfected with pET-14b; 2, E. coli transfected with
pET-IMNV105–297 before IPTG induction; 3, E. coli transfected with
pET-IMNV105–297 induced with IPTG; 4, soluble and 5, insoluble
fractions of the E. coli expressing rIMNV105–297 after IPTG induction;
6, purified rIMNV105–297; 7, western blot using anti-HisTag antibody
against purified rIMNV105–297; 8, western blot using anti-HisTag
antibody against E. coli mock control
Monoclonal antibodies against IMNV major capsid protein 13
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MAb used as negative control did not recognize any pro-
teins in any of the assays (data not shown).
Specific detection of IMNV in tissues of naturally
infected shrimps
In order to identify MAbs that are able to recognize the
native IMNV major capsid protein, immunodot blot assays
using anti-rIMNV105–297 MAbs were carried out with
homogenates of skeletal muscle from naturally infected
and uninfected L. vannamei shrimps. MAb 1.1D showed no
reaction, but MAbs 1.3H, 3.3G, 4.6C, and 5.4H were able
to recognize the presence of IMNV in infected shrimp
tissues and did not show any reaction against uninfected
shrimps (data not shown). MAbs 1.3H, 3.3G, 4.6C, and
5.4H were further screened by western blot against the
same homogenates of IMNV-infected and uninfected
L. vannamei tissues. A protein of *100 kDa could be
recognized by MAbs 1.3H, 4.6C, and 5.4H, but not by
MAb 3.3G, reinforcing their usefulness for the specific
detection of the IMNV major capsid protein (Fig. 3b).
None of the MAbs tested showed cross-reactivity with
uninfected shrimp tissues in this assay (Fig. 3b), as was
also observed for the anti-rabies virus MAb used as a
negative control (data not shown).
Detection and localization of IMNV in infected skeletal
tissues by immunohistochemistry
The three MAbs showing specific recognition of the
major capsid protein of IMNV in western blot assays
(1.3H, 4.6C, and 5.4H) were tested by immunohisto-
chemistry for the detection of IMNV in abdominal
skeletal muscle of infected L. vannamei, since replication
of the virus is prominent in this tissue [4, 13, 29]. MAbs
1.3H and 4.6C bound to viral inclusions in myonecrosis
foci in muscle samples from IMNV-infected shrimps, as
clearly revealed by the brownish color observed in
Fig. 4a–d, corresponding to areas of muscle fibrosis.
MAbs 1.3H and 4.6C showed no cross-reaction with
uninfected L. vannamei tissues by immunohistochemistry
(Fig. 4e–f). However, MAb 5.4H demonstrated nonspe-
cific binding to shrimp striated muscle (data not shown).
This result indicates that MAbs 1.3H and 4.6C are
promising tools for histopathology, allowing assessment
of viral distribution and cytolocation. No cross-reactivity
with L. vannamei tissues was observed while using the
unrelated anti-rabies-virus MAb (Fig. 4g). The specific
recognition by MAbs 1.3H and 4.6C was not affected by
putative conformational changes of the target epitope,
showing specific binding to both native and denatured
forms of the protein. Similar characteristics have already
been reported for MAbs produced against others shrimp
viruses, reinforcing their importance for development of
immunoassays [16–18].
In summary, this present study describes the generation
and characterization of two MAbs that bind with high
specificity to the major capsid protein of IMNV, since they
do not show any nonspecific recognition of proteins from
healthy shrimp tissues in immunodot blot, western blot, or
immunohistochemical analysis. Ongoing studies employ-
ing MAbs 1.3H and 4.6C are in progress for the purpose of
developing a fast and simple immunodiagnostic assays
such as immunochromatographic and agglutination tests.
Such development based on the MAbs described in this
study will allow early and specific diagnosis of IMNV
Fig. 3 Detection of IMNV in
naturally infected L. vannamei
tissue homogenate by western
blot using anti-rIMNV105–297
MAbs. a 15% SDS-PAGE
Coomassie-blue -tained gel;
b western blot of the same SDS-
PAGE using MAbs anti-
rIMNV105–297 1.3H, 4.6C, 5.4H
or 3.3G, as indicated; in lane 3,
MAb 1.3H was used. M,
BenchMark
TM
protein ladder
(Invitrogen); 1, striated muscle
homogenate from healthy
shrimp; 2, striated muscle
homogenate from IMNV-
infected shrimp; 3, purified
rIMNV105–297
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infection, contributing to minimizing the major economic
impact of this virus on shrimp farming and commerce.
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